Integrated Nanotherapeutics
PrivateLast Round
Grant
Mar 18, 2026
Total Funding Raised
$140,000
Momentum Score
50 /100
Company Overview
Integrated Nanotherapeutics is a biotechnology company that is developing a new class of therapeutics for antigen-specific immune tolerance using its proprietary multi-cargo lipid nanoparticles (LNPs) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Integrated Nanotherapeutics Comps
Public and private peers based on sector, stage, and business model.
Integrated Nanotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 18, 2026 | ||||
| Grant | Sep 9, 2024 | ||||
| Accelerator | Jun 1, 2023 | ||||
| Accelerator | Apr 1, 2023 | ||||
| Grant | Mar 18, 2019 |
Integrated Nanotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Western Economic Diversification Canada | Grant |
| Genome British Columbia | Grant |
| Creative Destruction Lab | Accelerator |
| National Research Council Canada Industrial Research Assistance Program | Accelerator |
| JDRF | Grant |
| Life Sciences BC | Accelerator |
| The University of British Columbia | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors increased 90% MoM.
- Mar 18, 2026
Received grant funding from Genome British Columbia and Genome Canada.
Integrated Nanotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Integrated Nanotherapeutics's valuation, stock price, and market status.
